Modifiable Risk Factors Impact Early Discontinuation of Adjuvant Endocrine Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Modifiable Risk Factors With Early Discontinuation of Adjuvant Endocrine Therapy: A Post Hoc Analysis of a Randomized Clinical Trial
JAMA Oncol 2021 Jun 17;[EPub Ahead of Print], B Yanez, RJ Gray, JA Sparano, RC Carlos, G Sadigh, SF Garcia, IF Gareen, TJ Whelan, GW Sledge, D Cella, LI WagnerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.